First-in-human trial for new lung cancer immunotherapy

Cancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer.

Read the full article here

Related Articles